NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
25 hedge funds and large institutions have $19.3M invested in NeuBase Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.64M | |
| 2 | +$449K | |
| 3 | +$201K | |
| 4 |
PPCM
Pillar Pacific Capital Management
Pacifica,
California
|
+$141K |
| 5 |
Jane Street
New York
|
+$121K |
Top Sellers
| 1 | -$99K | |
| 2 | -$85K | |
| 3 | -$72K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$38K |
| 5 |
Millennium Management
New York
|
-$37.2K |